Vita Life Sciences Limited is an Australian healthcare company that formulates, packages, and distributes over-the-counter medicines, complementary and alternative medicines, dietary supplements, and health foods. The company operates through its brand portfolio, which includes Herbs of Gold, VitaHealth, VitaScience, and VitaLife. It serves markets in Australia, Malaysia, Singapore, Thailand, Vietnam, China, and Indonesia. The VitaHealth brand was established in 1947, while Herbs of Gold was established in 1989. Vita Life Sciences was incorporated in 2000 and acquired its key brands in 2001. The company lists on the Australian Securities Exchange and employs teams of naturopaths, nutritionists, biotechnologists, and pharmacists to formulate products compliant with local regulatory standards in its operating regions.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Pharmaceuticals, Biotechnology & Life Sciences Homepage vitalifesciences.com
Sector Healthcare IR page vitalifesciences.com/investor-centre
Tags
dietary supplements, herbal medicines, vitamins, minerals, superfoods, over-the-counter medicines, complementary medicines, health foods, pharmaceuticals, consumer health, Herbs of Gold, VitaHealth, VitaScience, VitaLife
Press page —

Metrics

Valuation  
Market cap A$ 147.696M
P/E 13.54
P/BV 2.70
P/S 1.54
P/OCF 9.99
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE —
ROI —
ROIC —
Profit margin —
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 41.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Revenue — 93.27M 79.505M 73.427M 66.886M 57.101M 46.481M 42.452M 41.151M 37.204M 37.818M
Net profit — 10.426M 8.779M 9.078M 7.341M 8.247M 5.862M 3.094M 2.433M 2.856M 3.336M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Share price 2.5 2.44 — — — — — — — — —
P/OCF — 8.26 — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Vita Life Sciences Limited (ticker VLS), listed in Australia.